Fluoroquinolone antibiotics have been known to cause severe, multisystem adverse side effects, termed fluoroquinolone toxicity (FQT). This toxicity syndrome can present with adverse effects that vary from individual to individual, including effects on the musculoskeletal and nervous systems, among others. The mechanism behind FQT in mammals is not known, although various possibilities have been investigated. Among the hypothesized FQT mechanisms, those that could potentially explain multisystem toxicity include off-target mammalian topoisomerase interactions, increased production of reactive oxygen species, oxidative stress, and oxidative damage, as well as metal chelating properties of FQs. This review presents relevant information on fluoroquinolone antibiotics and FQT and explores the mechanisms that have been proposed. A fluoroquinolone-induced increase in reactive oxygen species and subsequent oxidative stress and damage presents the strongest evidence to explain this multisystem toxicity syndrome. Understanding the mechanism of FQT in mammals is important to aid in the prevention and treatment of this condition.
Skin cancer diagnoses and deaths continue to increase every year. With basal cell carcinoma (BCC) being the most common type of skin cancer diagnoses, establishing protective measurements against it are important. Surprisingly, sunscreen may not be as effective at protecting against basal cell carcinoma as it is for another non-melanoma type of skin cancer: squamous cell carcinoma. This paper aims to identify some differences between the two non-melanoma type cancers to find probable reasons sunscreen may be more effective at protecting against one over the other, as well as to find new solutions to protect against basal cell carcinoma. The results conclude that basal cell carcinoma does have UV-induced pathogenesis, in which case sunscreen is protective; however, it also revealed the need for ingredient studies and more sunscreen efficacy studies to determine other BCC pathogenesis pathways. Lastly, aided by dermatologist interviews, current interventions were established in order to provide greater protection against skin cancer. These include reforming the way commercials portray sunscreen to better educate the public about proper application and re-application, genetic testing for high-risk BCC markers, and an emphasis on sun education to the mothers of children.